Smoking Cessation
Conditions
Keywords
relapse, prevention, smoking, habit, Forever Free
Brief summary
The purpose of this study is to test different ways to help cancer patients maintain their smoking abstinence. Participants may receive educational materials as part of the study.
Detailed description
This study involves participation at four distinct time points over a one-year period. * Baseline assessment * 2-month follow-up telephone call * 6-month follow-up telephone call * 12-month follow-up telephone call
Interventions
BEHAVIORALUsual Care
Standard care includes routine assessment of smoking behavior and brief clinical intervention. Smoking counseling for all participants in the current study will be completed by a Certified Tobacco Treatment Specialist consisting consists of brief counseling (\<15 minutes) based on the 5 A's Clinical Practice Guidelines; Ask about tobacco use, Advise to quit, Assess willingness to make a quit attempt, Assist in quit attempt, Arrange for follow-up (Fiore et al., 2008). Patients receive information for local and state smoking resources (e.g., Quitline), pharmacotherapy options, and if interested, assistance with obtaining a prescription for pharmacotherapy. Follow-up with patients occurs at 2-weeks, only among those who are prescribed smoking medications (i.e., Varenicline, Bupropion).
BEHAVIORALSmoking Relapse Prevention for Cancer Patients (SRP-CaP)
The proposed multimodal intervention consists of a series of easy-to-read relapse prevention booklets (Forever Free) that have shown to be efficacious with a general smoking population (Brandon et al., 2000; 2004), and digital video disk (DVD) customized to the needs of cancer patients (to be developed in Year One).
Sponsors
National Cancer Institute (NCI)
H. Lee Moffitt Cancer Center and Research Institute
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
SINGLE (Outcomes Assessor)
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Have smoked at least 10 cigarettes per day for at least one year prior to cancer diagnosis * Able to read and write English * Able to give informed consent * Have quit smoking after receiving their cancer diagnosis * Have not quit greater than 3 months prior
Exclusion criteria
* Individuals who have been abstinent for greater than 3 months are not included because they are less likely to relapse. A quit will be defined as self-reported no smoking for 24 hours. Individuals with metastatic disease will be excluded because participation in the study might be burdensome.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Number of Participants with Relapse at 6 Months | 6 Months | Number of participants with smoking relapse at 6 months follow-up for each treatment arm. |
| Number of Participants with Relapse at 12 Months | 12 Months | Number of participants with smoking relapse at 12 months for each treatment arm. |
Countries
United States
Outcome results
None listed